Body fluid MMP-2 as a putative biomarker in metastatic breast cancer

  • Authors:
    • Sewon Noh
    • Jae-Joon Jung
    • Minkyu Jung
    • Ki-Hyang Kim
    • Ha‑Young Lee
    • Brandon Wang
    • Joanna Cho
    • Tae Soo Kim
    • Hei‑Cheul Jeung
    • Sun Young Rha
  • View Affiliations

  • Published online on: January 3, 2012     https://doi.org/10.3892/ol.2012.549
  • Pages: 699-703
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

In the present study, we investigated the role of matrix metalloproteinase (MMP)-2 and -9 as novel biomarkers in the body fluid of patients with metastatic breast cancer. We measured the expression of MMPs in 37 samples of body fluid (10 peritoneal and 27 pleural fluids) from metastatic breast cancer patients between 2000 and 2009. Zymography and ELISA assays were used to determine the cut-off level and to quantify MMP expression from a positive control, HT-1080 conditioned media. MMP expression in patient samples was measured with ELISA and compared with other clinical parameters. Ascitic carcinoembryonic antigen (CEA) and pleural CEA were measured in patient samples with a chemiluminescent enzyme immunoassay. Body fluid cytology had a positivity of 45% (9/20) for pleural fluid and 28.6% (2/7) for ascites. However, MMP-2 had a positivity of 85.2% (23/27) in 27 pleural fluid samples and 100% (10/10) in ascitic fluid with cut-off levels of 8.6 and 0.14 ng/ml for MMP-2 and -9, respectively. When body fluid CEA and MMP-2 were combined, the positivity improved to 96% in pleural fluid and 100% in ascites. MMP-2 expression in body fluid did not show any significant differences, but MMP-9 expression was lower in ascites than in pleural fluids (p<0.005). Our results suggest that MMP-2 expression in body fluid be used as an additive diagnostic marker for metastatic breast cancer patients.
View Figures
View References

Related Articles

Journal Cover

March 2012
Volume 3 Issue 3

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Noh S, Jung J, Jung M, Kim K, Lee HY, Wang B, Cho J, Kim T, Jeung HC, Rha S, Rha S, et al: Body fluid MMP-2 as a putative biomarker in metastatic breast cancer. Oncol Lett 3: 699-703, 2012
APA
Noh, S., Jung, J., Jung, M., Kim, K., Lee, H., Wang, B. ... Rha, S. (2012). Body fluid MMP-2 as a putative biomarker in metastatic breast cancer. Oncology Letters, 3, 699-703. https://doi.org/10.3892/ol.2012.549
MLA
Noh, S., Jung, J., Jung, M., Kim, K., Lee, H., Wang, B., Cho, J., Kim, T., Jeung, H., Rha, S."Body fluid MMP-2 as a putative biomarker in metastatic breast cancer". Oncology Letters 3.3 (2012): 699-703.
Chicago
Noh, S., Jung, J., Jung, M., Kim, K., Lee, H., Wang, B., Cho, J., Kim, T., Jeung, H., Rha, S."Body fluid MMP-2 as a putative biomarker in metastatic breast cancer". Oncology Letters 3, no. 3 (2012): 699-703. https://doi.org/10.3892/ol.2012.549